Skip to main content
All agencies

Defense Threat Reduction Agency (DTRA)

14 lobbying filings named this agency, 2025 to 2026. Those filers reported $645,000 of lobbying spend in total, across all the work each filing covers.

An LD-2 reports one money figure for the whole filing, covering every part of government it named. The dollar amounts here are the spend of filings that named Defense Threat Reduction Agency (DTRA), not money spent lobbying it. Money counts the latest version of each filing only; filing counts include ones a later amendment restated.

 Issues raised
  1. Defense 13 filings that named this body and this issue
  2. Health Issues 8 filings that named this body and this issue
  3. Veterans 7 filings that named this body and this issue
  4. Financial Institutions/Investments/Securities 4 filings that named this body and this issue
  5. Budget/Appropriations 3 filings that named this body and this issue
  6. Science/Technology 1 filing that named this body and this issue
  7. Transportation 1 filing that named this body and this issue
  8. Homeland Security 1 filing that named this body and this issue
 Filings by year
  • 2025 9 $235,000
  • 2026 5 $410,000

Bar length is filings that year against the busiest year. A year is the filing year, not the date lobbying happened.

 Clients lobbying here
  1. RELATIVITY SPACE $350,000 1 filing
  2. RECCE PHARMACEUTICALS LTD $140,000 7 filings
  3. ALLIANCE FOR BIOSECURITY $80,000 1 filing
  4. CYBERLUX CORPORATION $45,000 4 filings
  5. ACURX PHARMACEUTICALS, INC. $30,000 1 filing
 Firms filing on their behalf
  1. RELATIVITY SPACE $350,000 1 filing
  2. RK STRATEGIES, INC. $140,000 7 filings
  3. SQUIRE PATTON BOGGS $80,000 1 filing
  4. 1607 STRATEGIES, LLC $45,000 4 filings
  5. INNOVATIVE FEDERAL STRATEGIES, LLC $30,000 1 filing

Client and firm names are the filers' own text, not deduplicated: one company can appear under several spellings.

 Bills these filings cite most 11
  • H.R. 3838
    1 filing · Streamlining Procurement for Effective Execution and Delivery and National Defense Author…
  • H.R. 4026
    1 filing · POST Act of 2025
  • H.R. 5304
    1 filing · Departments of Labor, Health and Human Services, and Education, and Related Agencies Appr…
  • H.R. 8800
    1 filing · National Defense Authorization Act for Fiscal Year 2027
  • H.R. 8845
    1 filing · Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027
  • H.R. 9495
    1 filing · Department of Defense Appropriations Act, 2027
  • S. 2296
    1 filing · National Defense Authorization Act for Fiscal Year 2026
  • S. 2572
    1 filing · Department of Defense Appropriations Act, 2026
  • S. 2587
    1 filing · Departments of Labor, Health and Human Services, and Education, and Related Agencies Appr…
  • S. 4784
    1 filing · National Defense Authorization Act for Fiscal Year 2027
  • S. 4905
    1 filing · Space Ready 2.0 Act

Bills are parsed from the filings' own activity descriptions, so this is what lobbyists wrote down, not a record of contact with this body about that bill.

 Filings that named it 14
Q3 report
RK STRATEGIES, INC. for RECCE PHARMACEUTICALS LTD
3rd Quarter 2026 (July 1 - Sep 30) · District of Columbia · $20,000 income · posted Oct 20, 2026
View → Q3 report
RELATIVITY SPACE for RELATIVITY SPACE
3rd Quarter 2026 (July 1 - Sep 30) · California · $350,000 expenses · posted Oct 16, 2026
View → Q2 report
RK STRATEGIES, INC. for RECCE PHARMACEUTICALS LTD
2nd Quarter 2026 (Apr 1 - June 30) · District of Columbia · $20,000 income · posted Jul 18, 2026
View → Q1 report
RK STRATEGIES, INC. for RECCE PHARMACEUTICALS LTD
1st Quarter 2026 (Jan 1 - Mar 31) · District of Columbia · $20,000 income · posted Apr 20, 2026
View → Q1 termination
1607 STRATEGIES, LLC for CYBERLUX CORPORATION
1st Quarter 2026 (Jan 1 - Mar 31) · North Carolina · posted Jan 22, 2026
View → Q4 report
RK STRATEGIES, INC. for RECCE PHARMACEUTICALS LTD
4th Quarter 2025 (Oct 1 - Dec 31) · District of Columbia · $20,000 income · posted Jan 20, 2026
View → Q4 report
1607 STRATEGIES, LLC for CYBERLUX CORPORATION
4th Quarter 2025 (Oct 1 - Dec 31) · North Carolina · $15,000 income · posted Jan 20, 2026
View → Q3 report
1607 STRATEGIES, LLC for CYBERLUX CORPORATION
3rd Quarter 2025 (July 1 - Sep 30) · North Carolina · $15,000 income · posted Oct 20, 2025
View → Q3 report
RK STRATEGIES, INC. for RECCE PHARMACEUTICALS LTD
3rd Quarter 2025 (July 1 - Sep 30) · District of Columbia · $20,000 income · posted Oct 20, 2025
View → Q3 report
INNOVATIVE FEDERAL STRATEGIES, LLC for ACURX PHARMACEUTICALS, INC.
3rd Quarter 2025 (July 1 - Sep 30) · New York · $30,000 income · posted Oct 20, 2025
View → Q2 report
RK STRATEGIES, INC. for RECCE PHARMACEUTICALS LTD
2nd Quarter 2025 (Apr 1 - June 30) · District of Columbia · $20,000 income · posted Jul 21, 2025
View → Q2 report
SQUIRE PATTON BOGGS for ALLIANCE FOR BIOSECURITY
2nd Quarter 2025 (Apr 1 - June 30) · District of Columbia · $80,000 income · posted Jul 3, 2025
View → Q1 report
RK STRATEGIES, INC. for RECCE PHARMACEUTICALS LTD
1st Quarter 2025 (Jan 1 - Mar 31) · District of Columbia · $20,000 income · posted Apr 21, 2025
View → Q1 report
1607 STRATEGIES, LLC for CYBERLUX CORPORATION
1st Quarter 2025 (Jan 1 - Mar 31) · North Carolina · $15,000 income · posted Apr 18, 2025
View →

Source: federal Lobbying Disclosure Act filings. "Defense Threat Reduction Agency (DTRA)" is the filers' own entry from the LDA's list of government bodies. Rollups on this page refresh every six hours.

Report a problem